Spyre Therapeutics Inc. (SYRE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Spyre Therapeutics Inc.

    NASDAQ: SYRE · Real-Time Price · USD
    17.00
    0.01 (0.06%)
    At close: Sep 05, 2025, 3:59 PM
    17.00
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Spyre Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 886K 2.33M 18.74M
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a 886K 2.33M 18.74M
    Operating Income
    		 -208.57M -242.3M -84.78M -65.65M
    Interest Income
    		 21.31M 6.15M 837K 111K
    Pretax Income
    		 -207.97M -338.82M -83.95M -65.66M
    Net Income
    		 -208.02M -338.79M -83.81M -65.8M
    Selling & General & Admin
    		 45.78M 39.95M 28.53M 27.32M
    Research & Development
    		 162.79M 89.5M 58.58M 57.07M
    Other Expenses
    		 n/a 113.74M n/a n/a
    Operating Expenses
    		 208.57M 243.19M 87.11M 84.39M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 243.19M 87.11M 84.39M
    Income Tax Expense
    		 51K -26K -136K 141K
    Shares Outstanding (Basic)
    		 47.03M 6.9M 3.37M 2.63M
    Shares Outstanding (Diluted)
    		 47.03M 6.9M 3.37M 2.63M
    EPS (Basic)
    		 -0.56 -46.15 -24.86 -25.02
    EPS (Diluted)
    		 -0.56 -46.15 -24.86 -25.02
    EBITDA
    		 -207.97M -127.6M -82.82M -64.07M
    EBIT
    		 -207.97M -128.56M -84.78M -65.65M
    Depreciation & Amortization
    		 n/a 964K 1.96M 1.58M

    Add to Watchlist